Specialists Reach a Consensus on Chronic Cough Assessment and Diagnosis
Panelists reached a consensus on statements about chronic cough diagnosis, helping to solidify opinions that can assist in the future creation of assessment guidelines.
Related Articles
Clinical Perspectives Presented by:
Five-Year Outcomes With First-Line Nivolumab + Ipilimumab With Chemotherapy vs Chemotherapy in Patients With Metastatic NSCLC in CheckMate 9LA Please see US Full Prescribing Information…
The Future of Disease-Modifying Therapies for Patients With SMA
Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients aged 2 and older without early treatment.
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis
Once-daily roflumilast provides skin clearance and rapid itch relief with no limitation on duration of use.
FDA Approves Mepolizumab as First Once-Monthly Biologic for COPD With Eosinophilic Phenotype
FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.
Unmet Health Care and Health-Related Social Needs of Laundromat Users
Laundromats offer a promising outreach setting for Medicaid payers because Medicaid enrollees represent a majority of laundromat users and have disproportionately high levels of unmet…
JAK Inhibitors vs Cytokine Inhibitors: AAD 2025 Findings on Infection Risks
A panelist discusses how the comprehensive ADVANCES safety monitoring system data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) revealed distinct…
Female Patients With ILD Show Lower ICU Mortality Rates: Matthew Viggiano, MD
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital, shares findings on a study in which female patients with interstitial lung disease (ILD) admitted to…
Improving Pulmonary Embolism Outcomes in Intermediate-Risk Patients: Krunal Patel, MD
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital, discusses how early intervention within 12 hours improved hemodynamic measurements and clinical outcomes in…
Ensifentrine Shows Promise as Add-On, Stand-Alone Therapy in COPD: M. Bradley Drummond, MD, MHS
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient…
Sleep Patterns, Predictors, and Pharmacologic Interventions in the ICU
Research presented at the American Thoracic Society (ATS) 2025 International Conference used FDA-approved tools to see how sleep can impact other parts of recovery for…